I+D

The PREVENTLIT study shows that Lit-Control® reduces new episodes of renal lithiasis

Devicare is presenting the positive results of the PREVENTLIT clinical study today which have been published in Clinical Medicine Insights Urology. The results show the efficacy and tolerance of its products Lit-Control® pH Up and Lit-Control® pH Down to regulate urinary pH in patients with renal lithiasis. The study confirms that maintaining urinary pH within […]

The IMB-CNM-CSIC has successfully passed the inspection from the AEMPS and will now be an authorised sub-contractor for Devicare

July 11, 2019

The Microelectronic Institute of Barcelona-National Microelectronic Centre (IMB-CNM), one of Devicare’s leading suppliers, has successfully passed an inspection of its facilities by the Spanish Agency of Medicines and Medical Devices (AEMPS). The ICB-CNM is now accredited as an authorised sub-contractor by the AEMPS to carry out its activity in the medical devices sector.

The plan […]

Devicare participates in the leading lithiasis event in Spain and presents the results of the ‘Double J’ trial

February 7th, 2019

Devicare participated in the National Meeting of the Lithiasis, Endourology, Laparoscopy and Robotics Groups (LELR), held on 24 and 25 January in Palma de Mallorca. The plenary sessions focused on the medical and surgical handling of urinary lithiasis which affects 10% of the Spanish population. The final results of the “Double J” clinical […]

The ‘Double J’ clinical trial wins the Pedro Arregui award from the Spanish Urological Association

February 5th, 2019

During the 19th National Meeting of the Lithiasis, Endourology and Robotics Groups organised by the Spanish Urological Association on 24 and 25 January in Palma de Mallorca, Dr Jaime Fernández-Concha was recognised on behalf of the research team for the Multicenter, Controlled and Randomized clinical trial on urinary pH monitoring and nutraceutical intervention […]

The European Parliament votes to support IP-intensive SMEs like Devicare

 

 

 

 

 

 

 

January 21st, 2019

The European Parliament voted to mobilise almost €700 billion in investments to boost competitiveness and growth by supporting IP-intensive enterprises through InvestEU programme, on January 16. The InvestEU, which is part of the EU’s Multi-Annual Financial (MFF) Framework 2021-2027, brings together the various instruments to expand the Juncker Plan model.

IP Europe Alliance, which […]

Devicare announces the positive results of the clinical trial with Lit-Control® to prevent the encrustation of catheters in patients with lithiasis

Devicare and nine leading Spanish hospitals in urology have successfully completed the clinical trial which demonstrates the efficacy of the combined use of a medical device (Lit-Control® pH Meter) and a nutraceutical (Lit-Control® pH Down) to prevent the encrustation of double J catheters by monitoring urinary pH and supplying phytates (crystallisation inhibitors).

The results of this […]

Dr Carlos Torrecilla: “We have the solution to prevent the encrustation of double J catheters”

Interview

December 12, 2018

Dr Carlos Torrecilla, director of the Lithiasis Unit of the Bellvitge University Hospital and national coordinator of the Lithiasis and Endourology Group of the Spanish Association of Urology, is the principal investigator of a clinical trial sponsored by Devicare conducted in nine Spanish university hospitals (Bellvitge, La Paz, Río Hortega, Puigvert Foundation, San […]

Devicare gets the patent for its sensor technology in Europe and USA

Devicare has obtained the patent in Europe and the United States for its electrochemical ion sensor, which is integral to the Lit-Control® pH Meter product for frequent urinary conditions, thus making progress in its intellectual and industrial protection strategy and gaining access to key markets in medical and health technologies.

The approval of this product profile […]

Devicare promotes a pioneering clinical trial to prevent the calcification of double J stent catheters

Devicare and nine leading hospitals in urology have started the pioneering international “Double J” study to evaluate the combined use of a medical device and a nutraceutical in controlling urinary pH and inhibiting crystallisation in order to prevent the calcification of double J stent catheters and reduce the number of associated complications.

“The calcification of a […]

Devicare patents a new sensor for the Lit-Control® pH Meter

Devicare has obtained the patent in Spain for a new electrochemical ion sensor, which is the most advanced of its type on the market, improving the features of the Lit-Control pH Meter® medical device for self-monitoring chronic urological diseases (lithiasis, infections, overactive bladder, calcification of urinary catheters, etc.). Specifically, the sensor incorporates a reference electrode […]